All News

SAN ANTONIO -- Attacking two separate breast cancer pathways with adjuvant therapy can double the disease-free period after surgery for women whose metastatic tumors are estrogen receptor-positive and HER2-positive, researchers reported here.

SAN ANTONIO -- Attacking two separate breast cancer pathways with adjuvant therapy can double the disease-free period after surgery for women whose metastatic tumors are estrogen receptor-positive and HER2-positive, researchers reported here.

SAN ANTONIO -- Some women with ductal carcinoma in situ (DCIS) can safely skip radiation therapy and be treated with lumpectomy alone, a researcher said here.

SAN ANTONIO -- Some women with ductal carcinoma in situ (DCIS) can safely skip radiation therapy and be treated with lumpectomy alone, a researcher said here.

SAN ANTONIO -- The annual incidence of breast cancer has fallen dramatically, coinciding with the end of the era of hormone replacement therapy, revealed National Cancer Institute SEER data.

SAN ANTONIO -- The annual incidence of breast cancer has fallen dramatically, coinciding with the end of the era of hormone replacement therapy, revealed National Cancer Institute SEER data.

SAN ANTONIO -- The annual incidence of breast cancer has fallen drastically, coinciding with the end of the hormone replacement therapy era, according to SEER data from the National Cancer Institute. After a steady rise during the past 20 years, the incidence dropped 7% from 2002 to 2003, reported investigators at the San Antonio Breast Cancer Symposium. The absolute reduction could be as many as 14,000 breast cancer cases per year.

SAN ANTONIO -- The annual incidence of breast cancer has fallen drastically, coinciding with the end of the hormone replacement therapy era, according to SEER data from the National Cancer Institute. After a steady rise during the past 20 years, the incidence dropped 7% from 2002 to 2003, reported investigators at the San Antonio Breast Cancer Symposium. The absolute reduction could be as many as 14,000 breast cancer cases per year.

ROCKVILLE, Md. -- Acting with uncommon speed, the FDA today approved Celebrex for the pain of juvenile rheumatoid arthritis-less than a month after an advisory committee recommended that it do so.

NEW YORK -- Community-based interventionalists and surgeons can be trained to perform catheter-based carotid stenting in high-risk patients just as well as those who tested the devices in the studies that led to FDA approvals, researchers reported.

NEW YORK -- Community-based interventionalists and surgeons can be trained to perform catheter-based carotid stenting in high-risk patients just as well as those who tested the devices in the studies that led to FDA approvals, researchers reported.

SAN ANTONIO -- Breast cancer patients may get similar benefit with less toxicity from adjuvant chemotherapy containing Taxotere and Herceptin but not the cardiotoxic anthracycline Adriamycin, researchers said.

SAN ANTONIO -- Breast cancer patients may get similar benefit with less toxicity from adjuvant chemotherapy containing Taxotere and Herceptin but not the cardiotoxic anthracycline Adriamycin, researchers said.

LUND, Sweden -- Men are more likely than women to achieve rheumatoid arthritis remission, researchers here have found.

LUND, Sweden -- Men are more likely than women to achieve rheumatoid arthritis remission, researchers here have found.

ROCKFORD, Ill. -- Even experienced gastroenterologists may miss neoplastic lesions if they hurry through screening colonoscopies, according to a small study here.

ROCKFORD, Ill. -- Even experienced gastroenterologists may miss neoplastic lesions if they hurry through screening colonoscopies, according to a small study here.

ROCKVILLE, Md. -- Health care costs are gobbling up more family income than they did a decade ago, according to a report by federal researchers.